• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合疫苗对猪胸膜肺炎放线杆菌实验性攻毒的保护效力

Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae.

作者信息

Byrd W, Harmon B G, Kadis S

机构信息

Department of Medical Microbiology, College of Veterinary Medicine, University of Georgia, Athens 30602.

出版信息

Vet Immunol Immunopathol. 1992 Nov;34(3-4):307-24. doi: 10.1016/0165-2427(92)90172-m.

DOI:10.1016/0165-2427(92)90172-m
PMID:1455686
Abstract

In an attempt to protect pigs against swine pleuropneumonia induced by Actinobacillus pleuropneumoniae (SPAP) by neutralizing the effects of three virulence factors of A. pleuropneumoniae--the capsular polysaccharide (CP), the lipopolysaccharide (LPS), and the hemolysin protein (HP)--two subunit conjugate vaccines were prepared by covalently coupling the CP to the HP and the LPS to the HP. The CP, LPS, and HP were isolated from A. pleuropneumoniae, strain 4074, serotype 1, and the protective efficacy of the conjugate vaccines in swine experimentally infected with A. pleuropneumoniae was evaluated. Following a booster vaccination, a significant (P < 0.05) IgG antibody response to the CP, LPS, and HP was detected in the vaccinated pigs. The pigs vaccinated with the CP-HP and LPS-HP conjugates exhibited significantly less mortality (P < 0.05) and significantly greater weight gain (P < 0.001) than unvaccinated pigs. Vaccinated pigs exhibited significantly fewer and less extensive gross pulmonary lesions (P < 0.001) when compared with unvaccinated pigs. Thus, on the basis of mortality, weight gains, and pulmonary lesion formation, the two conjugate vaccines used in conjunction with one another provide noticeable protective efficacy against SPAP.

摘要

为了通过中和胸膜肺炎放线杆菌的三种毒力因子——荚膜多糖(CP)、脂多糖(LPS)和溶血素蛋白(HP)的作用来保护猪免受胸膜肺炎放线杆菌诱导的猪胸膜肺炎(SPAP),通过将CP与HP共价偶联以及将LPS与HP共价偶联制备了两种亚单位结合疫苗。CP、LPS和HP从血清型1的胸膜肺炎放线杆菌4074菌株中分离出来,并评估了结合疫苗对实验感染胸膜肺炎放线杆菌的猪的保护效力。加强免疫后,在接种疫苗的猪中检测到对CP、LPS和HP有显著(P<0.05)的IgG抗体反应。与未接种疫苗的猪相比,接种CP-HP和LPS-HP结合物的猪死亡率显著降低(P<0.05),体重增加显著更大(P<0.001)。与未接种疫苗的猪相比,接种疫苗的猪肺部肉眼可见病变显著更少且范围更小(P<0.001)。因此,基于死亡率、体重增加和肺部病变形成情况,两种结合疫苗联合使用对SPAP具有显著的保护效力。

相似文献

1
Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae.结合疫苗对猪胸膜肺炎放线杆菌实验性攻毒的保护效力
Vet Immunol Immunopathol. 1992 Nov;34(3-4):307-24. doi: 10.1016/0165-2427(92)90172-m.
2
Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.亲和纯化溶血素疫苗对实验性猪胸膜肺炎的保护效力
J Vet Med Sci. 1997 Feb;59(2):115-20. doi: 10.1292/jvms.59.115.
3
Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants.针对胸膜肺炎放线杆菌毒力决定因素的结合疫苗的制备、表征及免疫原性
Infect Immun. 1992 Aug;60(8):3042-51. doi: 10.1128/iai.60.8.3042-3051.1992.
4
Evaluation of the protective efficacy of Actinobacillus pleuropneumoniae serotype 1 detoxified lipopolysaccharides or O-polysaccharide-protein conjugate in pigs.胸膜肺炎放线杆菌1型解毒脂多糖或O-多糖-蛋白质偶联物对猪的保护效果评估。
Res Vet Sci. 1998 Sep-Oct;65(2):165-7. doi: 10.1016/s0034-5288(98)90170-9.
5
Evaluation of pig lungs following an experimental challenge with Actinobacillus pleuropneumoniae serotype 1 and 5 in pigs inoculated with either hemolysin protein and/or outer membrane proteins.对接种溶血素蛋白和/或外膜蛋白的猪用胸膜肺炎放线杆菌血清型1和5进行实验性攻毒后对猪肺的评估。
FEMS Microbiol Lett. 1995 Sep 15;131(3):329-35. doi: 10.1111/j.1574-6968.1995.tb07796.x.
6
Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.猪胸膜肺炎放线杆菌apxIA突变体的特性及免疫原性
Vet Microbiol. 2006 Dec 20;118(3-4):230-9. doi: 10.1016/j.vetmic.2006.07.013. Epub 2006 Jul 22.
7
An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.对胸膜肺炎放线杆菌血清型1和15抗体在亚单位疫苗及活的链霉素依赖型胸膜肺炎疫苗所提供的保护作用中的评估。
Aust Vet J. 2004 Dec;82(12):773-80. doi: 10.1111/j.1751-0813.2004.tb13248.x.
8
Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.在猪中通过口服表达Apx毒素的酿酒酵母诱导针对胸膜肺炎放线杆菌攻击的保护性免疫反应。
Vet Immunol Immunopathol. 2013 Jan 15;151(1-2):132-9. doi: 10.1016/j.vetimm.2012.11.003. Epub 2012 Nov 9.
9
Serological response to Actinobacillus pleuropneumoniae serovar 7 infection in a commercial pig herd.商业猪群中对胸膜肺炎放线杆菌7型感染的血清学反应
Aust Vet J. 1991 Nov;68(11):349-52. doi: 10.1111/j.1751-0813.1991.tb00732.x.
10
Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.一种抗胸膜肺炎放线杆菌感染的DIVA亚单位疫苗的研发。
Vaccine. 2006 Nov 30;24(49-50):7226-37. doi: 10.1016/j.vaccine.2006.06.047. Epub 2006 Jul 7.

引用本文的文献

1
Actinobacillus pleuropneumoniae encodes multiple phase-variable DNA methyltransferases that control distinct phasevarions.胸膜肺炎放线杆菌编码多个相变异 DNA 甲基转移酶,这些酶控制不同的相变异。
Nucleic Acids Res. 2023 Apr 24;51(7):3240-3260. doi: 10.1093/nar/gkad091.
2
Mix-and-Match System for the Enzymatic Synthesis of Enantiopure Glycerol-3-Phosphate-Containing Capsule Polymer Backbones from , , and .从,, 和 混合搭配系统用于酶法合成手性纯甘油-3-磷酸含胶囊聚合物主链
mBio. 2021 Jun 29;12(3):e0089721. doi: 10.1128/mBio.00897-21. Epub 2021 May 26.
3
An enzyme-based protocol for cell-free synthesis of nature-identical capsular oligosaccharides from serotype 1.
基于酶的无细胞合成方法,用于从血清型 1 中合成天然存在的荚膜寡糖。
J Biol Chem. 2020 Apr 24;295(17):5771-5784. doi: 10.1074/jbc.RA120.012961. Epub 2020 Mar 9.
4
epsilon toxin vaccine candidate lacking toxicity to cells expressing myelin and lymphocyte protein.对表达髓磷脂和淋巴细胞蛋白的细胞无毒性的ε毒素候选疫苗。
NPJ Vaccines. 2019 Jul 30;4:32. doi: 10.1038/s41541-019-0128-2. eCollection 2019.
5
A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens.一种新型囊泡聚合酶家族在革兰氏阴性病原体中产生类似肽聚糖的囊多糖聚合物。
mBio. 2018 May 29;9(3):e00641-18. doi: 10.1128/mBio.00641-18.
6
Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.使用荚膜多糖糖缀合物疫苗预防猪链球菌2型感染
Infect Immun. 2016 Jun 23;84(7):2059-2075. doi: 10.1128/IAI.00139-16. Print 2016 Jul.
7
Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.利用细菌糖基化作用生产糖缀合物,从疫苗到人源化糖蛋白。
J Pharm Pharmacol. 2015 Mar;67(3):338-50. doi: 10.1111/jphp.12321. Epub 2014 Sep 22.
8
Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice.评估多组分重组疫苗对胸膜肺炎放线杆菌的小鼠保护作用。
Acta Vet Scand. 2010 Sep 11;52(1):52. doi: 10.1186/1751-0147-52-52.
9
Genomic relatedness among Actinobacillus pleuropneumoniae field strains of sterotypes 1 and 5 isolated from healthy and diseased pigs.从健康猪和患病猪中分离出的1型和5型胸膜肺炎放线杆菌田间菌株的基因组相关性。
Can J Vet Res. 1999 Jul;63(3):170-6.
10
Experimental vaccination of pigs with an Actinobacillus pleuropneumoniae serotype 5b capsular polysaccharide-tetanus toxoid conjugate.用胸膜肺炎放线杆菌5b型荚膜多糖-破伤风类毒素结合物对猪进行实验性疫苗接种。
Acta Vet Scand. 1997;38(3):283-93. doi: 10.1186/BF03548491.